Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Taranabant in obese and overweight patients
NCT00384605Phase 3Terminated
- Sponsor
- Merck & Co.
- Start
- Oct 2006
- Primary completion
- Jan 2008
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of taranabant in obesity, sponsored by Merck & Co.. Started Oct 2006; status: terminated.
02
Drugs
taranabant
03
Conditions
obesity
Beyond the preview
Go deeper on NCT00384605.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00384605.